Takeda Pharmaceutical Company

Takeda Pharmaceutical Company Limited^[1]
	Global headquarters in Nihonbashi
Native name	武田薬品工業株式会社
Romanized name	Takeda Yakuhin Kōgyō kabushiki gaisha
Formerly	Chobei Takeda & Co., Ltd. (1925–1943); Takeda Pharmaceutical Industries, Ltd. (English name only 1943–1961); Takeda Chemical Industries, Ltd. (English name only 1961–2004)
Company type	Public KK
Traded as	TYO: 4502; NAG: 4502; FSE: 4502; NYSE: TAK; Nikkei 225 component (TYO); TOPIX Core30 component (TYO);
Industry	Pharmaceuticals
Founded	Doshomachi, Osaka, Japan (12 June 1781)
Founder	Chobei Takeda I
Headquarters	Nihonbashi, Chuo, Tokyo, Japan
Key people	Yasuchika Hasegawa; (Chairman of the Board); Christophe Weber; (President & CEO)
Revenue	¥4.03 trillion (FY 2022)
Operating income	¥490.51 billion (FY 2022)
Net income	¥317.02 billion (FY 2022)
Total assets	¥13.96 trillion (FY 2022)
Total equity	¥6.35 trillion (FY 2022)
Owners	Nippon Life (2.24%); BNY Mellon (5.39%); JPMorgan Chase (3.50%); State Street Corporation (1.50%);
Number of employees	49,578 (2019); 18,378 in United States ; 5,350 in Japan;
Website	www.takeda.com
	Footnotes / references; ^ a b c d e "Financial Results for Fiscal 2023" (PDF). Takeda Pharmaceutical Company Limited. May 11, 2023. Retrieved December 27, 2023. ;

The Takeda Pharmaceutical Company Limited^[1] (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year.^[7] The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo.^[8]^[9] In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.^[10] As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.^[11]

^ ^a ^b "Company Facts | Takeda". www.takeda.com.
^ "The History of Takeda – 1781 to 1944 | Takeda".
^ Chris Gallagher (2015-03-15). Muralikumar Anantharaman (ed.). "Japan drugmaker Takeda says Christophe Weber to become CEO April 1". Reuters. Retrieved 2015-04-20.
^ ^a ^b ^c "Share Data | Takeda".
^ "Working at Takeda Pharmaceuticals NA".
^ "Takeda offers early retirement to workers as young as 30". Nikkei Asia.
^ "Financial Results for Fiscal 2012" (PDF). Takeda Pharmaceutical Company Limited. 2013-05-09. Retrieved 2013-06-13.
^ "FAQ." Takeda Pharmaceutical Company. Retrieved on 2011-02-02. "Q : Where is Takeda located? A : The Head Office is located in Osaka, Japan, and the Tokyo Head Office is located in Tokyo, Japan."
^ "Overview." Takeda Pharmaceutical Company. Retrieved on 2011-02-02. "Headquarters Head Office 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645" and "Tokyo Head Office 12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668"
^ "100 Best Companies to Work For 2012". Fortune. 2012-02-06. Retrieved 2018-03-29.^{[dead link]}
^ "Christophe Weber". Takeda. Archived from the original on 2024-04-15. Retrieved 2024-04-15.